|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Note receivables | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total note receivables | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes receivable | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total interest receivable | ||||||||||||||||||||
| Intangible Assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Noncurrent assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Loan payable, related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total loan payable, related party | ||||||||||||||||||||
| Convertible note, net of debt discount - current portion | ||||||||||||||||||||
| Contingent funding liabilities | ||||||||||||||||||||
| Operating lease liability - current | ||||||||||||||||||||
| Notes payable – current portion | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total notes payable – current portion | ||||||||||||||||||||
| Purchase price payable | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Note payable, net of debt discount - current portion | ||||||||||||||||||||
| Development agreement liability - current portion | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable- related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable- related party | ||||||||||||||||||||
| Convertible notes, net of debt discount | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Operating lease liability - net of current portion | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total notes payable | ||||||||||||||||||||
| Note payable, net of debt discount | ||||||||||||||||||||
| Total development agreement liability | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Noncurrent liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.00001 par value; 100,000,000 shares authorized; 41,064,146 and 40,630,815 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 1,448,331 and 1,015,000 shares unvested as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
